Table 1 Patient characteristics and operative details
Patients characteristics (n = 158) | n(%)I mean ± SD or median [IQR] |
|---|---|
Age (years) | 74 [69,78] |
Male (%) | 105 (66.5%) |
BMI (kg/m2) | 25.8 ± 4.7 |
Acute aortic syndrome | 43 (27.2%) |
Ruptured aneurysm | 35 (22.2%) |
Contained rupture of aneurysm | 3 (1.9%) |
New onset penetrating ulcer | 3 (1.9%) |
With increasing back pain | 2 (1.2%) |
LVEF (%) | 55 [50; 60] |
Coronary artery disease | 72 (45.6%) |
NYHA IV | 8 (5.5%) |
Atrial fibrillation or flutter | 23 (14.6%) |
Preoperative creatinine level (mg/dL) | 1.00 [0.79, 1.40] |
Preoperative EGFR (mL/in/1.73m2) | 72.0 ± 29.7 |
Prior stroke | 6 (3.8%) |
Prior procedure on aorta | 19 (12.0%) |
Logistic Euroscore | 14.7 [9.1, 25.0] |
Euroscore 2 | 3.1 [1.8, 4.8] |
Maximum aneurysm diameter (mm) | 63.9 [58.7, 74.1] |
Aneurysm thrombosed part (%) | 48.7 [33.3, 60.5] |
Operative details | |
Duration of TEVAR (min) | 113 [68, 160] |
Percutaneous vascular access | 150 (94.9%) |
Proximal landing zones | |
0 | 3 (1.9%) |
1 | 6 (3.8%) |
2 | 72 (45.6%) |
3 | 51 (32.3%) |
4 | 26 (16.5%) |
LCCA-LSA or debranching* | 70 (44.3%) |
Stents combined length (mm) | 250 [164, 367] |
Aortic coverage (%) | 36.6 [28.0, 44.8] |
Distance from distal stent to coeliac trunk (mm) | 62 [30, 111] |
Contrast used (ml) | 100 [75, 149] |
Dose area product (µg/m2) | 18,512 [9716, 33717] |